Foamix Pharmaceuticals CEO On The Company's IPO, Status Of Trial Drugs
December 18, 2014 at 15:10 PM EST
Foamix Pharmaceuticals Ltd (NASDAQ: FOMX), a pharmaceutical company specializing in skin conditions, recently had a successful IPO in ...